Internal Medicine
Hematology
Blood in Sputum (hemoptysis)

Blood In Sputum (Hemoptysis)

Introduction

Hemoptysis, the coughing up of blood from the respiratory tract, is a significant clinical presentation that Canadian medical students must understand thoroughly for the MCCQE1 exam. This guide provides a comprehensive overview of hemoptysis, focusing on its relevance to Canadian healthcare and the MCCQE1 preparation process.

🇨🇦

This guide is specifically tailored for Canadian medical students preparing for the MCCQE1 exam, incorporating Canadian guidelines and healthcare practices.

Definition and Classification

Hemoptysis is defined as the expectoration of blood originating from the tracheobronchial tree or lung parenchyma. It's crucial to differentiate it from hematemesis (vomiting of blood) and pseudohemoptysis (blood from the upper respiratory tract).

Classification of Hemoptysis

<30 mL/24 hours

Etiology

Understanding the causes of hemoptysis is crucial for MCCQE1 preparation. The mnemonic "BATTLE CAMP" can help Canadian medical students remember the common causes:

  • Bronchiectasis

  • Arteriovenous malformation

  • Tuberculosis (TB)

  • Tumor (lung cancer)

  • Lung abscess

  • Embolism (pulmonary)

  • Coagulopathy

  • Anticoagulant use

  • Mitral stenosis

  • Pneumonia

🍁

In Canada, the most common causes of hemoptysis are bronchitis, bronchiectasis, and lung cancer. TB is less common but still important, especially in high-risk populations.

Canadian Epidemiology

Understanding the Canadian context is crucial for MCCQE1 success:

  • Lung cancer is the leading cause of cancer-related deaths in Canada, with an estimated 29,800 new cases in 2020.
  • TB incidence in Canada is low (4.9 per 100,000 population in 2017), but higher in certain populations:
    • Indigenous peoples
    • Foreign-born individuals from high-incidence countries

Diagnostic Approach

For the MCCQE1 exam, remember this step-wise approach to diagnosing hemoptysis:

History

  • Quantity and duration of hemoptysis
  • Associated symptoms (fever, weight loss, dyspnea)
  • Risk factors (smoking, occupational exposures)

Physical Examination

  • Vital signs
  • Respiratory system examination
  • Cardiovascular examination

Investigations

  • Chest X-ray
  • Complete blood count (CBC)
  • Coagulation profile
  • Sputum analysis (culture, cytology)
  • CT chest (if initial workup inconclusive)
  • Bronchoscopy (if localization needed or massive hemoptysis)

Management

Management of hemoptysis depends on the severity and underlying cause. For MCCQE1 preparation, focus on these key points:

  1. Mild Hemoptysis:

    • Treat underlying cause
    • Outpatient management if stable
  2. Moderate to Severe Hemoptysis:

    • Hospitalization
    • Airway protection
    • Bronchial artery embolization if needed
  3. Massive Hemoptysis:

    • ICU admission
    • Airway protection (intubation if necessary)
    • Bronchial artery embolization or surgery
💡

Remember the ABC approach (Airway, Breathing, Circulation) for managing massive hemoptysis in emergency situations.

Canadian Guidelines

The Canadian Thoracic Society provides guidelines for managing hemoptysis:

  1. Initial assessment should include chest X-ray and CBC.
  2. CT chest is recommended if the cause is not apparent on chest X-ray.
  3. Bronchoscopy is indicated for localization in massive hemoptysis or if malignancy is suspected.
  4. Bronchial artery embolization is the preferred first-line treatment for massive hemoptysis in most cases.

Key Points to Remember for MCCQE1

  • 🇨🇦 Differentiate hemoptysis from hematemesis and pseudohemoptysis
  • 🇨🇦 Use the "BATTLE CAMP" mnemonic for common causes
  • 🇨🇦 Consider TB in high-risk Canadian populations
  • 🇨🇦 Understand the step-wise diagnostic approach
  • 🇨🇦 Know the management strategies for different severities of hemoptysis
  • 🇨🇦 Familiarize yourself with Canadian guidelines for hemoptysis management

Sample Question

# Sample Question

A 65-year-old man presents to the emergency department with coughing up bright red blood. He has a 40 pack-year smoking history and reports a 5 kg weight loss over the past 3 months. His vital signs are stable, and chest examination reveals decreased breath sounds in the right upper lobe. Which one of the following is the most appropriate next step in management?

- [ ] A. Prescribe oral antibiotics and follow up in one week
- [ ] B. Perform bronchoscopy
- [ ] C. Order sputum cytology
- [ ] D. Initiate anticoagulation therapy
- [ ] E. Perform chest X-ray

Explanation

The correct answer is:

  • E. Perform chest X-ray

Explanation: In this case, the patient presents with hemoptysis and has risk factors for lung cancer (age, smoking history, weight loss). According to Canadian guidelines, the initial assessment for hemoptysis should include a chest X-ray. This non-invasive test can provide valuable information about potential causes such as lung masses, infiltrates, or cavitary lesions. If the chest X-ray is inconclusive or suspicious, further investigations like CT chest or bronchoscopy may be warranted.

References

  1. Canadian Thoracic Society. (2018). Canadian Thoracic Society guideline for the management of spontaneous pneumothorax. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine, 2(Sup1), 17-35.

  2. Government of Canada. (2021). Tuberculosis in Canada. Retrieved from https://www.canada.ca/en/public-health/services/diseases/tuberculosis.html (opens in a new tab)

  3. Canadian Cancer Society. (2021). Lung cancer statistics. Retrieved from https://www.cancer.ca/en/cancer-information/cancer-type/lung/statistics/ (opens in a new tab)

  4. Larici, A. R., Franchi, P., Occhipinti, M., Contegiacomo, A., del Ciello, A., Calandriello, L., ... & Bonomo, L. (2014). Diagnosis and management of hemoptysis. Diagnostic and Interventional Radiology, 20(4), 299-309.

  5. Cordovilla, R., Bollo de Miguel, E., Nuñez Ares, A., Cosano Povedano, F. J., Herráez Ortega, I., & Jiménez Merchán, R. (2016). Diagnosis and treatment of hemoptysis. Archivos de Bronconeumología (English Edition), 52(7), 368-377.